Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Depreciation and Depletion (2020 - 2025)

Biofrontera has reported Depreciation and Depletion over the past 6 years, most recently at $36000.0 for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $36000.0 for Q4 2025, down 5.26% from a year ago — trailing twelve months through Dec 2025 was $100000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $100000.0, changed 0.0%.
  • Depreciation and Depletion for Q4 2025 was $36000.0 at Biofrontera, up from $17000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for BFRIW hit a ceiling of $38000.0 in Q4 2024 and a floor of $17000.0 in Q3 2025.
  • Median Depreciation and Depletion over the past 5 years was $22000.0 (2023), compared with a mean of $25263.2.
  • Biggest five-year swings in Depreciation and Depletion: fell 21.21% in 2022 and later soared 80.95% in 2024.
  • Biofrontera's Depreciation and Depletion stood at $29000.0 in 2021, then dropped by 27.59% to $21000.0 in 2022, then changed by 0.0% to $21000.0 in 2023, then soared by 80.95% to $38000.0 in 2024, then dropped by 5.26% to $36000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $36000.0 (Q4 2025), $17000.0 (Q3 2025), and $22000.0 (Q2 2025) per Business Quant data.